Primary Site >> Stomach Cancer

Gene >> IL3

Journal: J Cell Physiol. 1991 Feb;146(2):251-7.
Title: IL-3 specifically inhibits GM-CSF binding to the higher affinity receptor.
Author: Taketazu, F|Chiba, S|Shibuya, K|Kuwaki, T|Tsumura, H|Miyazono, K|Miyagawa, K|Takaku, F
PMID: 1825663
Journal: Blood. 1992 Jul 15;80(2):374-81.
Title: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.
Author: Turner, A M|Zsebo, K M|Martin, F|Jacobsen, F W|Bennett, L G|Broudy, V C
PMID: 1378316
Journal: Mol Biother. 1992 Jun;4(2):83-6.
Title: Augmentation of human lymphokine-activated killer cell activity in splenic lymphocytes by the combination of low-dose interleukin 2 plus interleukin 3.
Author: Okuno, K|Ohnishi, H|Shilayama, Y|Hirohata, T|Ozaki, M|Yasutomi, M
PMID: 1515099
Journal: Gastroenterology. 1994 Aug;107(2):543-7.
Title: Interleukin 6-producing gastric carcinoma with fever, hypergammaglobulinemia, and plasmacytosis in bone marrow.
Author: Tatsuno, I|Nishikawa, T|Sasano, H|Shizawa, S|Iwase, H|Satoh, S
PMID: 8039631
Journal: Int J Oncol. 2012 Jan;40(1):93-8.
Title: Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning.
Author: Shibata-Minoshima, Fumi|Oki, Toshihiko|Doki, Noriko|Nakahara, Fumio|Kageyama, Shun-Ichiro|Kitaura, Jiro|Fukuoka, Junya|Kitamura, Toshio
PMID: 21874235
Journal: Am J Cancer Res. 2015 Oct 15;5(11):3376-88. eCollection 2015.
Title: The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.
Author: Ock, Chan-Young|Nam, Ah-Rong|Bang, Ju-Hee|Kim, Tae-Yong|Lee, Kyung-Hun|Han, Sae-Won|Im, Seock-Ah|Kim, Tae-You|Bang, Yung-Jue|Oh, Do-Youn
PMID: 26807318